They metabolize carbohydrates via the butyryl-CoA: acetate CoA-transferase pathway and butyrate kinase terminal enzymes to produce most of butyrate
Non-diabetic patients actually avoid hypoglycemia risks that diabetic users face, though they still require medical supervision for dose adjustment and side effect management
This is especially important for patients who have any GI-related problems: reflux/heartburn, SIBO/SIFO, chronic constipation, leaky gut, patients who are on acid blockers, etc
Recent findings Clinical trials and meta-analyses show GLP-1RAs achieve marked fat mass loss, preferentially reducing VAT, with modest proportional declines in LBM
Irritability and anxiety Some community reports describe irritability, restlessness, or heightened anxiety, occasionally framed as overstimulation
A quick and safe approach to providing your body with the nourishment it needs is through intravenous (IV) hydration